Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)

Auteurs

Antoine Vasseur, Luc Cabel, Olivier Tredan, Marion Chevrier, Coraline Dubot, Véronique Lorgis, William Jacot, Anthony Goncalves, Marc Debled, Christelle Levy, Jean-Marc Ferrero, Christelle Jouannaud, Elisabeth Luporsi, Marie-Ange Mouret-Reynier, Florence Dalenc, Jerome Lemonnier, Alexia Savignoni, Marie-Laure Tanguy, Francois-Clement Bidard, Jean-Yves Pierga